When will we see the full potential of vaccines?
In-house modelling suggests roughly 75 million more lives could have been saved over 50 years had vaccines been equitably available. An Axmed white paper.
Axmed Global Health Advisory
1 minute read
This white paper from Axmed Global Health Advisory explores a critical question at the heart of global health equity: how many more lives could be saved if vaccines were not just effective, but equitably available, accessible, and affordable to all.
Drawing on in-house modelling and sharp policy insight, the paper reveals a sobering reality: approximately 75 million additional lives could have been saved over the past 50 years. The paper outlines what it will take to close this staggering gap and ensure vaccines reach everyone, everywhere.
The full potential of vaccines (white paper)
PDF, 27 MB
Insights
Keep reading
Is Regulatory Approval The Happy Ever After? What Comes After the 'Regulatory Finish Line'
Reflections from PharmaReg AfriSummit 2026 on connecting regulatory approval, procurement, financing and logistics to real patient access.
- PDF
Why the new normal in global health requires a new access model
Development financing has changed permanently. Axmed Global Health Advisory's Access360 framework builds access strategy into product development.
Axmed Global Health Advisory
How we are making pharmaceutical quality scalable and accessible with AI
How Axmed turns day-long manual prequalification and GMP and GDP audit work into real-time quality intelligence with AI. By Sofia Radley-Searle, COO.
Sofia Radley-Searle